Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 24: 853-856, 1978;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Albers, J. J.
Right arrow Articles by Shlagenhaft, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Albers, J. J.
Right arrow Articles by Shlagenhaft, A.

Clinical Chemistry, Vol 24, 853-856, Copyright © 1978 by American Association for Clinical Chemistry

Multi-laboratory comparison of three heparin-Mn2+ precipitation procedures for estimating cholesterol in high-density lipoprotein

JJ Albers, GR Warnick, D Wiebe, P King, P Steiner, L Smith, C Breckenridge, A Chow, K Kuba, S Weidman, H Arnett, P Wood and A Shlagenhaft

Plasma high-density lipoprotein is commonly estimated by measuring the cholesterol remaining in plasma supernatant solutions after other lipoproteins, which contain apolipoprotein B, are precipitated with heparin and Mn2+. The method (method I) now in use by the Lipid Research Clinics, in which Mn2+ is at 46 mmol/liter final concentration, is reasonably accurate, but precipitation and sedimentation of lipoproteins other than high-density lipoproteins is often incomplete. We evaluated two modifications of method I. In method II, the Mn2+ concentration was doubled; the second modification (method III) included the increased Mn2+ concentration in a combined heparin Mn2+ reagent, decreased sample volume (2 ml), and a shorter incubation time (10 min at room temperature). The percentages of samples with turbid supernates (i.e., incomplete sedimentation) by methods I, II, and III were 9, 3, and 2%, respectively. Among non-turbid supernates, the percentages of samples containing measurable apolipoprotein B (incomplete precipitation) were 79, 19, and 16%, respectively. We conclude that method III is the most convenient and accurate of the three procedures.


The following articles in journals at HighWire Press have cited this article:


Home page
Am. J. Clin. Nutr.Home page
A. Motard-Belanger, A. Charest, G. Grenier, P. Paquin, Y. Chouinard, S. Lemieux, P. Couture, and B. Lamarche
Study of the effect of trans fatty acids from ruminants on blood lipids and other risk factors for cardiovascular disease
Am. J. Clinical Nutrition, March 1, 2008; 87(3): 593 - 599.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
E. Ingelsson, E. J. Schaefer, J. H. Contois, J. R. McNamara, L. Sullivan, M. J. Keyes, M. J. Pencina, C. Schoonmaker, P. W. F. Wilson, R. B. D'Agostino, et al.
Clinical Utility of Different Lipid Measures for Prediction of Coronary Heart Disease in Men and Women
JAMA, August 15, 2007; 298(7): 776 - 785.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
I. Gigleux, J. Gagnon, A. St-Pierre, B. Cantin, G. R. Dagenais, F. Meyer, J.-P. Despres, and B. Lamarche
Moderate Alcohol Consumption Is More Cardioprotective in Men with the Metabolic Syndrome
J. Nutr., December 1, 2006; 136(12): 3027 - 3032.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. J. Tremblay, B. Lamarche, J. S. Cohn, J.-C. Hogue, and P. Couture
Effect of Ezetimibe on the In Vivo Kinetics of ApoB-48 and ApoB-100 in Men With Primary Hypercholesterolemia
Arterioscler. Thromb. Vasc. Biol., May 1, 2006; 26(5): 1101 - 1106.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
A.-M. Paradis, B. Fontaine-Bisson, Y. Bosse, J. Robitaille, S. Lemieux, H. Jacques, B. Lamarche, A. Tchernof, P. Couture, and M.-C. Vohl
The peroxisome proliferator-activated receptor {alpha} Leu162Val polymorphism influences the metabolic response to a dietary intervention altering fatty acid proportions in healthy men
Am. J. Clinical Nutrition, February 1, 2005; 81(2): 523 - 530.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
R. Rej
Clinical Chemistry through Clinical Chemistry: A Journal Timeline
Clin. Chem., December 1, 2004; 50(12): 2415 - 2458.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
A. J. Tremblay, B. Lamarche, I. L. Ruel, J.-C. Hogue, J. Bergeron, C. Gagne, and P. Couture
Increased production of VLDL apoB-100 in subjects with familial hypercholesterolemia carrying the same null LDL receptor gene mutation
J. Lipid Res., May 1, 2004; 45(5): 866 - 872.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
G. T. Russo, S. Friso, P. F. Jacques, G. Rogers, D. Cucinotta, P. W. F. Wilson, J. M. Ordovas, I. H. Rosenberg, and J. Selhub
Age and Gender Affect the Relation between Methylenetetrahydrofolate Reductase C677T Genotype and Fasting Plasma Homocysteine Concentrations in the Framingham Offspring Study Cohort
J. Nutr., November 1, 2003; 133(11): 3416 - 3421.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
M.-E. Paradis, P. Couture, Y. Bosse, J.-P. Despres, L. Perusse, C. Bouchard, M.-C. Vohl, and B. Lamarche
The T111I mutation in the EL gene modulates the impact of dietary fat on the HDL profile in women
J. Lipid Res., October 1, 2003; 44(10): 1902 - 1908.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
I. Lemieux, B. Lamarche, C. Couillard, A. Pascot, B. Cantin, J. Bergeron, G. R. Dagenais, and J.-P. Despres
Total Cholesterol/HDL Cholesterol Ratio vs LDL Cholesterol/HDL Cholesterol Ratio as Indices of Ischemic Heart Disease Risk in Men: The Quebec Cardiovascular Study
Arch Intern Med, December 10, 2001; 161(22): 2685 - 2692.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
M. Pirro, J. Bergeron, G. R. Dagenais, P.-M. Bernard, B. Cantin, J.-P. Despres, and B. Lamarche
Age and Duration of Follow-up as Modulators of the Risk for Ischemic Heart Disease Associated With High Plasma C-Reactive Protein Levels in Men
Arch Intern Med, November 12, 2001; 161(20): 2474 - 2480.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. T. Meinardi, J. A. Gietema, W. T. A. van der Graaf, D. J. van Veldhuisen, M. A. Runne, W. J. Sluiter, E. G. E. de Vries, P. B. H. Willemse, N. H. Mulder, M. P. van den Berg, et al.
Cardiovascular Morbidity in Long-Term Survivors of Metastatic Testicular Cancer
J. Clin. Oncol., April 1, 2000; 18(8): 1725 - 1732.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. Couture, J. D. Otvos, L. A. Cupples, C. Lahoz, P. W. F. Wilson, E. J. Schaefer, and J. M. Ordovas
Association of the C-514T Polymorphism in the Hepatic Lipase Gene With Variations in Lipoprotein Subclass Profiles : The Framingham Offspring Study
Arterioscler. Thromb. Vasc. Biol., March 1, 2000; 20(3): 815 - 822.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. Couture, L. D. Brun, F. Szots, M. Lelievre, D. Gaudet, J.-P. Despres, J. Simard, P. J. Lupien, and C. Gagne
Association of Specific LDL Receptor Gene Mutations With Differential Plasma Lipoprotein Response to Simvastatin in Young French Canadians With Heterozygous Familial Hypercholesterolemia
Arterioscler. Thromb. Vasc. Biol., June 1, 1998; 18(6): 1007 - 1012.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
J.-P. Despres, B. Lamarche, P. Mauriege, B. Cantin, G. R. Dagenais, S. Moorjani, and P.-J. Lupien
Hyperinsulinemia as an Independent Risk Factor for Ischemic Heart Disease
N. Engl. J. Med., April 11, 1996; 334(15): 952 - 958.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1978 by the American Association for Clinical Chemistry.